Urology Divisions Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
BJU Int. 2011 Jul;108(2):276-9. doi: 10.1111/j.1464-410X.2010.09801.x. Epub 2010 Nov 17.
• To determine the comparative efficacy of tamsulosin and nifedipine in medical expulsive therapy (MET) for distal ureteric stones with renal colic.
• We evaluated the comparative efficacy of tamsulosin and nifedipine in MET in a prospective randomized trial of 3189 outpatients from 10 centres in China. • Eligible patients randomly received tamsulosin or nifedipine. Efficacies of the two agents in MET were compared at 4 weeks. • The primary endpoint was overall stone-expulsion rate. • Secondary endpoints were stone-expulsion time, rate of pain relief therapy, mean analgesic consumption for renal colic recurrence, and side-effects incidence.
• Stone-expulsion rates in the tamsulosin group (group 1) were greater than those in the nifedipine group (group 2; P < 0.01). • There was a significant variation in stone-expulsion rates and times between groups 1 and 2 (P < 0.01); with improvements in stone-expulsion rate and time significantly better in group 1 than in group 2. • There was a significant variation in the rate of pain relief therapy for renal colic recurrence between groups 1 and 2 (P < 0.01); patients in group 1 required significantly less analgesics than those in group 2 (P < 0.01). • There were no statistically significant differences in side-effects incidence between the groups.
• Administration of tamsulosin and nifedipine in MET was determined to be safe and effective for distal ureteric stones with renal colic. • Tamsulosin was significantly better than nifedipine in relieving renal colic and facilitating ureteric stone expulsion.
我们在中国 10 个中心的 3189 名门诊患者中进行了一项前瞻性随机试验,评估坦索罗辛和硝苯地平在 MET 中的比较疗效。
符合条件的患者随机接受坦索罗辛或硝苯地平治疗。4 周后比较两种药物在 MET 中的疗效。
主要终点是整体结石排出率。
次要终点是结石排出时间、疼痛缓解治疗率、肾绞痛复发时平均镇痛药用量和不良反应发生率。
坦索罗辛组(第 1 组)的结石排出率大于硝苯地平组(第 2 组;P < 0.01)。
第 1 组和第 2 组之间的结石排出率和时间存在显著差异(P < 0.01);第 1 组的结石排出率和时间明显优于第 2 组。
第 1 组和第 2 组肾绞痛复发的疼痛缓解治疗率存在显著差异(P < 0.01);第 1 组患者需要的镇痛药明显少于第 2 组(P < 0.01)。
两组不良反应发生率无统计学差异。
坦索罗辛和硝苯地平在 MET 治疗肾绞痛合并远端输尿管结石是安全有效的。
坦索罗辛在缓解肾绞痛和促进输尿管结石排出方面明显优于硝苯地平。